TS
TANUJ SHARMA
SYNTEKABIO, BNJBIOPHARMA, Yonsei University, CSIR-Central Drug Research Institute Molecular and Structural Biology Division, Panjab University
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · SARS-CoV-2 and COVID-19 Research · Synthesis and biological activity
0000-0003-0054-6153
Employment
-
SYNTEKABIO PRINCIPAL SCIENTIST2024 - Present
-
BNJBIOPHARMA Team Leader2022 - 2024
Education
-
Yonsei University Post Doctoral Fellow2020 - 2022
-
CSIR-Central Drug Research Institute Molecular and Structural Biology Division SRF2015 - 2018
-
CSIR-Central Drug Research Institute Molecular and Structural Biology Division JRF2013 - 2014
-
Panjab University MASTER'S IN SCIENCE2007 - 2009
-
Himachal Pradesh University BACHELOR IN SCIENCE2005 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (30)
- Improved molecular graph aggregation strategies for robust prediction of ADME and pharmacokinetic properties Save
- Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19 Save
- Combining structure-based pharmacophore modeling and machine learning for the identification of novel BTK inhibitors Save
- Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19 Save
- Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight Save
- β-Sitosterol-D-Glucopyranoside Mimics Estrogenic Properties and Stimulates Glucose Utilization in Skeletal Muscle Cells Save
- Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19 Save
- Targeting Mycobacterium Tuberculosis Enoyl‐Acyl Carrier Protein Reductase Using Computational Tools for Identification of Potential Inhibitor and their Biological Activity Save
- Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study Save
- Unbuttoning the impact of N501Y mutant RBD on viral entry mechanism: A computational insight Save
- Computational investigation of phytomolecules as resuscitation-promoting factor B (RpfB) inhibitors for clinical suppression of Mycobacterium tuberculosis dormancy reactivation Save
- Identification of Potential Inhibitors of Cathepsin‐B using Shape & Pharmacophore‐based Virtual Screening, Molecular Docking and Explicit Water Thermodynamics Save
- Peptide Combination Generator: a Tool for Generating Peptide Combinations Save
- Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor inC. elegansmodel of Parkinson’s disease Save
- HIV-1 Nef physically associate with CAMKIIδ – ASK-1 complex to inhibit p38MAPK signalling and apoptosis in infected cells Save
- In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95) Save
- Synthesis and study of benzofuran-pyran analogs as BMP-2 targeted osteogenic agents Save
- Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of Plasmodium Save
- Phosphorylation of Wat1, human Lst8 homolog is critical for the regulation of TORC2 –Gad8 dependent pathway in fission yeast Schizosacchromyces pombe Save
- A facile tandem double-dehydrative-double-Heck olefination strategy for pot-economic synthesis of ( E )-distyrylbenzenes as multi-target-directed ligands against Alzheimer's disease employing C. elegans model Save